Here's why Admedus Ltd has soared 4% higher today

Admedus Ltd (ASX:AHZ) is selling its flagship product globally. The question remains, just how big could this company actually be?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares of Admedus Ltd (ASX: AHZ) received a welcome boost this morning after the company announced that it had been granted a Medical Device Licence to sell its flagship CardioCel product in Canada. The shares rose 3.9% to be trading at 13.5 cents, compared to a 1% gain for the benchmark ALL ORDINARIES (INDEXASX: XAO) index.

So What: CardioCel is a regenerative tissue product which is gaining popularity amongst surgeons as a way to repair congenital holes and other damage inside the human heart. Gaining a licence for the Canadian market is another important stepping stone for the company which has already received 510k clearance in the U.S. and CE Mark approval in Europe. In Australia, it is also under the early access Authorised Prescriber Scheme.

Following today's announcement, Admedus' CEO Lee Rodne said: "The Canadian approval is another important step in the global launch of CardioCel and will add revenue growth for the Admedus Group."

Now What: Following on from an incredible run in 2013 (which saw its shares rally approximately 675%), Admedus' shares have actually fallen by 12.9% since the beginning of the year. As an investor who bought into the stock late in the game, I still like what the future could hold for Admedus and am certainly excited by its global expansion strategy.

Motley Fool contributor Ryan Newman owns shares in Admedus Ltd.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »